Further Studies Needed To Assess Safety, Efficacy Of Superselective Ophthalmic Artery Chemotherapy

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Wednesday, March 23, 2011

Comments

Ocular Surgery News

Superselective ophthalmic artery chemotherapy should be restricted to more advanced cases of retinoblastoma and should only be given in one eye, a study found.

Full Story

Retina Products and Equipment »

All of the following are true of Sjögren Syndrome except:
1. hyaline
2. cholesterol
3. calcium
4. amyloid
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Further Studies Needed To Assess Safety, Efficacy Of Superselective Ophthalmic Artery Chemotherapy

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

All of the following are true of Sjögren Syndrome except:

AdGlare RMR Ad

Featured Products

CareCloud Central

VISUPLAN 500 Non-Contact Tonometer

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us